Diabetes Care Devices - Czechia | Statista Market Forecast

In Czechia, revenue in the Diabetes Care Devices market market is projected to reach US$68.90m in 2024.
It is anticipated that revenue will demonstrate an annual growth rate (CAGR 2024-2029) of 12.45%, leading to a market volume of US$123.90m by 2029.
When compared globally, the highest revenue will be generated the United States, with figures of US$11.71bn in 2024.
Czechia is witnessing a growing demand for innovative diabetes care devices, driven by increasing awareness and proactive management of chronic health conditions.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Czechia is experiencing considerable growth, fueled by increased prevalence of diabetes, advancements in technology, and heightened awareness of diabetes management, leading to greater demand for innovative and user-friendly devices.

Customer preferences: In Czechia, there is a notable shift towards personalized diabetes care solutions, as consumers prioritize devices that offer tailored insights into their health. This trend is influenced by a growing interest in holistic wellness and self-management, prompting demand for continuous glucose monitors and smart insulin delivery systems. Additionally, an aging population and increasing urbanization are driving the preference for user-friendly, connected devices that integrate seamlessly with mobile health applications, enhancing overall diabetes management while fostering community support.

Trends in the market: In Czechia, the Diabetes Care Devices Market is experiencing a surge in the adoption of advanced monitoring technologies, particularly continuous glucose monitors (CGMs) and smart insulin delivery systems. This trend reflects a broader shift towards digital health solutions, as patients seek more personalized management of their conditions. The rise of connected devices that sync with mobile health applications is enhancing patient engagement and self-management. As the population ages and urban lifestyles dominate, industry stakeholders must prioritize user-friendly designs and interoperability to meet evolving consumer demands, ensuring better health outcomes and fostering community support.

Local special circumstances: In Czechia, the Diabetes Care Devices Market is shaped by a well-established healthcare system and a strong emphasis on preventive care. The country's high educational standards foster a tech-savvy population that is receptive to innovative diabetes management solutions. Additionally, regulatory support for medical device approvals accelerates the introduction of new technologies. Cultural factors, such as a communal approach to health, enhance patient engagement in diabetes management. As urbanization increases, the demand for integrated digital health solutions grows, driving advancements in user-friendly devices tailored to local needs.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Czechia is significantly influenced by macroeconomic factors, including national economic stability, healthcare funding, and global economic trends. A robust economy, underpinned by steady GDP growth, supports increased healthcare spending and investment in medical technology. Fiscal policies promoting innovation and research in healthcare further enhance market dynamics. Additionally, the rising prevalence of diabetes and related conditions drives demand for advanced diabetes care devices. As global trends shift towards digitalization and personalized medicine, Czechia is well-positioned to adopt innovative technologies that improve patient outcomes and streamline healthcare delivery.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.